Diffuse large B-cell lymphoma: the fast lymphoma that chemo can cure, and the six cycles of R-CHOP
Last updated September 3, 2026.
Diffuse large B-cell lymphoma (DLBCL) is the commonest fast-growing non-Hodgkin lymphoma. Fast is the honest word, and it cuts both ways: this lymphoma grows in weeks to months, and it also responds to treatment in a way slow cancers often do not. The headline that people deserve to hear early is that DLBCL is curable. Standard chemotherapy, a combination called R-CHOP given every three weeks for six cycles, cures roughly six or seven out of ten people, and many of the rest are helped by newer treatments that did not exist a decade ago. It can start at any adult age, is commonest over 65, and often arrives dramatically: a lump in the neck, armpit, or groin that grows noticeably over weeks, drenching night sweats, fevers without infection, or weight falling without trying. Diagnosis needs a biopsy of the lump itself, plus scans to map where it is and blood tests to check how the body is coping. Treatment usually starts quickly once confirmed, and that speed is about the lymphoma's pace, not about losing the chance to think.
What does it look like?
Most people notice a lump that is growing, not sore, and not going away, often in the neck. The symptoms doctors call B symptoms matter for staging: drenching night sweats that soak the sheets, fevers that come without any infection, and losing a tenth of your weight over six months without trying. Depending on where it grows, DLBCL can press on things: a full belly and poor appetite if it involves the abdomen, breathlessness or a swollen face and arms if it presses in the chest, or back pain and weakness if it presses near the spine. The pace is part of the picture; weeks, not years, is the usual story from first symptom to diagnosis.
Why does it happen?
A B lymphocyte, one of the immune system's antibody-making cells, acquires the wrong set of genetic changes and starts dividing out of control. For most people there is no identifiable cause, and it is nobody's fault. Known associations include a weakened immune system, some infections, and older age, but most people diagnosed have none of these. It is not contagious, and it is not caused by stress, diet, or anything you did or failed to do.
How is it treated?
- R-CHOP is the backbone. Six cycles, one every three weeks, as an outpatient. It combines chemotherapy with rituximab, an antibody that targets B cells. Hair usually goes and grows back; anti-sickness drugs have transformed what chemo feels like compared with a generation ago. Many people keep working in a reduced way between cycles.
- The fever rule is absolute during chemo. A temperature of 100.4 degrees F or higher is a same-hour call to the emergency card number, not something to leave until morning, because chemo lowers the infection-fighting white cells and a fever can become dangerous fast.
- A scan mid-treatment and at the end tells the story. Most people see the lumps melt away. A PET scan after treatment confirms the response, and the word everyone waits for is complete remission.
- If it comes back or does not respond, there are real backstops. Second-line chemotherapy with a stem cell transplant, and CAR-T cell therapy, where your own immune cells are re-engineered to hunt the lymphoma, have changed what relapse means. Relapse is frightening and is no longer a closed door.
When does it need the prompt review?
Before treatment, a lump growing over weeks, drenching night sweats, or unexplained fevers deserve a same-week appointment, and breathlessness with facial or arm swelling needs same-day assessment. During treatment, the fever rule above is the emergency. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
My oncologist said cure. Am I being sold something?
No, and the numbers are worth hearing plainly. R-CHOP cures roughly six or seven out of ten people with DLBCL outright, meaning the lymphoma never comes back. That is unusually good for a cancer this fast, and it is the reason oncologists use the word without flinching. The honest companions are that some lymphomas do return, that a scan during and after treatment tracks the truth rather than the hope, and that relapse today meets transplants and CAR-T cell therapy, not a closed door. Your oncologist is describing the standard of care, not selling it.
My sister had chemo in the nineties. Is it still like that?
It is not, and the difference is not cosmetic. The anti-sickness drugs now used alongside chemo have transformed the experience; the vomiting you remember is largely preventable now, not endured as routine. Rituximab, the R in R-CHOP, did not exist in the nineties and is a large part of why DLBCL outcomes improved so much. People still have hard days, especially the few after each cycle, and hair usually still goes and grows back. But the gray year you remember is not the template for the six cycles ahead of you.
What are the six cycles of R-CHOP actually like?
Each cycle is an outpatient infusion lasting several hours, then three weeks at home before the next. Most people find a rhythm by cycle two: a few heavy days right after the infusion with tiredness and queasiness, then a steady climb back toward normal before the next round. Many people keep working in a reduced way between cycles. Hair usually goes within the first few weeks and grows back after treatment ends. The staff will hand you an emergency card with the fever rule, and that card, plus the infusion team, becomes your world for about five months.
What is the fever rule everyone keeps mentioning?
A temperature of 100.4 degrees F or higher during chemo is a same-hour call to the emergency number on your chemo card. Not something to leave until morning, not something to watch and hope. Chemo lowers the white cells that fight infection, and in that window an ordinary infection can become dangerous within hours. The emergency team would always rather see you and send you home than hear about it late. Keep a working thermometer, know where the card is, and make sure whoever lives with you knows the rule too.
What if it comes back?
Relapse is the fear everyone carries, and it deserves a factual answer. If DLBCL returns or does not respond fully, the second line is usually different chemotherapy followed by a stem cell transplant for those fit enough, and CAR-T cell therapy, where your own immune cells are re-engineered to hunt the lymphoma, has changed what relapse means over the past few years. People are still cured at the second line; it is a harder road, not a closed door. The scan at the end of your six cycles is where you will get the first clear word on remission.
How do I get through the nights before treatment starts?
The sleepless stretch between diagnosis and cycle one is one of the worst parts of the whole thing, and it is normal. What helps most people: writing the 3 a.m. questions down for the team rather than answering them from the internet, asking the oncologist's nurse for the practical walkthrough of cycle one so the unknowns shrink, and saying yes when people offer specific help like driving you to the first infusion. The fear usually drops sharply once treatment starts, because waiting is harder than doing. If the nights stay impossible, tell the team; short-term help with sleep is part of cancer care, not an extra.